Duke Capital Limited

Duke Capital Limited operates as a private equity firm primarily engaged in Management Buyouts (MBOs), buy-and-build strategies, mid-market investments, minority buyouts, restructuring endeavors, and royalty financing for small to medium-sized enterprises (SMEs). The firm explicitly avoids investing in early-stage ventures, businesses with inherently tight profit margins, and does not provide venture capital funding. While its investment scope spans all sectors, Duke Capital exhibits a distinct preference for companies in manufacturing, services, healthcare, and IT services. Equity investments typically range from £5 million (approximately $6.36 million) to £30 million (around $38.18 million), targeting businesses with an EBITDA between £2 million ($2.54 million) and £10 million ($12.72 million). Additionally, the firm offers debt financing, with loan sizes generally falling between £10 million (approximately $12.72 million) and £30 million (roughly $38.18 million). Key investment criteria include a strong emphasis on intellectual property assets and financially stable, cash-generating businesses. It also favors companies with minimal or no existing debt, and partnerships with owners who wish to retain significant control or with management teams pursuing buyout opportunities. A core strategy involves providing capital in exchange for a modest share of future revenues, via royalty agreements. The firm shows a preference for businesses operating under government or regulatory licenses and generally seeks board representation within its portfolio companies, where it typically acquires minority stakes. Established in 2015, Duke Capital Limited is headquartered in Guernsey, with additional operational bases in both Guernsey and London, United Kingdom.

Duke Capital Limited trades as DUKE.L on LSE. The company is classified in Financial Services / Asset Management and reports in GBP.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £15.01M of revenue and £2.00M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Duke Capital Limited can be compared against peers such as abrdn European Logistics Income plc, Augmentum Fintech PLC, CT UK High Income B Share Ord, CT UK High Income Ord, CVC Income & Growth Limited, Majedie Investments PLC.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £129.66M, beta of 0.36, and return on equity of +1.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

DUKE.L currently shows total debt of £88.33M and beta of 0.36. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.dukecapital.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.